• Print

released: 14 Sep 2011 author: AIHW media release

This report presents projections of the incidence of end-stage kidney disease treated with dialysis or kidney transplantation (treated ESKD) for the period 2010 to 2020. This information is important for health service planning and resource allocation in the future. The projections are made by sex at national and state/territory levels, and for end-stage kidney disease (ESKD) patients with diabetes when commencing treatment. The incidence of treated ESKD is projected to continue to rise over the next decade; increasing by nearly 80% between 2009 and 2020. The proportion of those commencing ESKD treatment with diabetes is also expected to increase, from 45% in 2009 to 64% in 2020.

ISBN 978-1-74249-201-8; Cat. no. PHE 150; 64pp.; Internet only

Publication

Publication table of contents

  • Preliminary
    • Title and verso pages
    • Contents
    • Acknowledgments
    • Abbreviations
    • Summary
      • Overall picture
      • Projections at the national level
      • Projections at the state/territory level
  • Body Content
    1. Introduction
      • Background
      • Key features of treated ESKD in Australia
      • Australia's experience in an international context
      • About this report
        • Data sources
        • Statistical methods
        • Interpretations of these projections
    1. Projection results at the national level
      • Projected incidence of treated ESKD in Australia
        • Alternative model
      • Projected incidence of treated ESKD patients with diabetes
    1. Projection results at the state/territory level
      • Projected incidence of treated ESKD in NSW/ACT
      • Projected incidence of treated ESKD in Victoria
      • Projected incidence of treated ESKD in Queensland
      • Projected incidence of treated ESKD in Western Australia
      • Projected incidence of treated ESKD in South Australia
      • Projected incidence of treated ESKD in Tasmania
      • Projected incidence of treated ESKD in the Northern Territory
      • Variations in the incidence rates of treated ESKD by state/territory
    1. Discussion
      • Key results
        • The continued increase in treated ESKD
        • The role of increasing prevalence of diabetes
        • State/territory differences in the incidence of treated ESKD
      • Alternative model
      • The issue of untreated ESKD
      • Interpretation of these projections
  • End matter
    • Appendix 1 Statistical tables
    • Appendix 2 Statistical methods
      • Age-period model in prediction of disease incidence
        • The Poisson regression model
        • Selection of starting year of base data
        • Model fitting
    • List of tables
    • List of figures
    • References

Recommended citation

AIHW 2011. Projections of the incidence of treated end-stage kidney disease in Australia, 2010-2020. Cat. no. PHE 150. Canberra: AIHW. Viewed 23 July 2017 <http://www.aihw.gov.au/publication-detail/?id=10737419875>.

Request an alternative format

Please contact us if you need information from the website presented in an alternative format for accessibility reasons.